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Recurrent infections are very common in children and a
major challenge for pediatricians. They affect the chil-
dren’s quality of life, cause absences from school and lost
parental working days, and repeated medical examina-
tions, hospital admissions as well as antibiotic therapies
lead to high costs for society. Given their prevalence and
clinical importance, various prevention strategies have
been developed.
Some of these strategies have considered that innate
and adaptive immunity are strictly related with gut
microbiota and interact in the modulation of host’s reac-
tivity to infections. Variations in gut microbiota related
to age, nutrition or underlying disease may influence
immune system defenses against viruses and bacteria.
Furthermore, disturbed gut colonization patterns are pro-
posed to be associated with the development of allergic
disease. This explains why probiotics represent an impor-
tant option in the prophylaxis and the management of
recurrent infectious diseases as well as allergic diseases.
However, the incomplete understanding of what consti-
tutes a healthy gut microbiota that promotes tolerance,
remains a challenge. Further understanding of gut micro-
bial functions may pave the way for more effective pre-
vention and treatment strategies.
Another approach used for prevention of recurrent
infections is represented by the administration of immu-
nostimulants: i.e. molecules of bacterial or synthetic ori-
gin that interact with immunological mechanisms in
vitro and in vivo. Pidotimod (3-L-pyroglutamil-L-thiazio-
lidine-4-carboxylic acid) is a synthetic dipeptide which
stimulates the phagocytic activity of polymorphonuclear
leukocytes, enhances the killing activity of human alveo-
lar macrophages, increases the cytotoxic activity of nat-
ural killer cells, and stimulates cytokine production. It
also influences the maturation and activity of dendritic
cells by increasing the expression of the key surface
markers that help to trigger T cell activation and
increased IL-12 production. The majority of studies have
shown that the number of infections decreases after pido-
timod treatment, but they are affected by some methodo-
logical weaknesses. Further studies are urgently needed
to confirm the pediatric population that should have
the greatest benefit with the administration of
immunostimulants.
More studies are needed to identify the most promis-
ing probiotic strains and study populations, and to eval-
uate the mechanisms behind the possible effects of
probiotics on OM.
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